Omics data contains signal from the molecular, physical, and kinetic inter-and intracellular interactions that control biological systems. Matrix factorization techniques can reveal low-dimensional structure from high-dimensional data that reflect these interactions. These techniques can uncover new biological knowledge from diverse high-throughput omics data in topics ranging from pathway discovery to time course analysis. We review exemplary applications of matrix factorization for systems-level analyses. We discuss appropriate application of these methods, their limitations, and focus on analysis of results to facilitate optimal biological interpretation. The inference of biologically relevant features with matrix factorization enables discovery from highthroughput data beyond the limits of current biological knowledge-answering questions from high-dimensional data that we have not yet thought to ask.
dimensional structure while preserving as much information as possible from the original data (see Box 1) .
When applied to high-throughput omics data, MF techniques learn two matrices: one describes the structure between features (e.g., genes) and another the structure between samples (Fig 2) . Here, we call the former gene-level matrix the Amplitude matrix and the latter sample-level matrix the Pattern matrix. There are numerous approaches to MF, including both gradient-based and probabilistic methods (Box 1).
Additional terms have been coined for the Amplitude and Pattern matrices based upon the MF problem applied and on the specific application to high-throughput biological data. Other reviews discuss the mathematical and technical details of MF techniques [5] [6] [7] [8] and their applications to microarray data [9] .
Here, we focus on the biological applications of MF techniques and the interpretation of their results since the advent of sequencing technologies. We describe a variety of MF techniques applied to high-throughput data analysis and compare and contrast their use for biological inference. Many techniques described are for sequencing data that is preprocessed with log transformation [10] or models of sequencing depth [11] , while others directly model read counts [12] . We focus on examples in pathway analysis, subtype and clonal identification, time course analysis, multi-omics integration, and single cell data to present a field with much wider applications.
Data-driven gene sets from MF provide context-dependent coregulated gene modules and pathway annotations
Genomics data are often interpreted by identifying molecular changes in sets of genes annotated to functionally related modules or pathways, called gene sets [13, 14] .
Often the association between gene sets and functions used are based upon human curation of the literature [15, 16] . Such set-level interpretations often lack important contextual information [13, 17, 18] and cannot describe genes with unknown function or genes associated with new functional mechanisms.
The amplitude matrix from MF analysis can be used both for literature-based gene set analysis and to define new data-driven gene signatures (Fig 3) . The values in each column of these amplitude matrices are continuous weights describing relative contribution of a molecule in each inferred factor. In cases where factors distinguish CBPs, the relative weights of these molecules can be associated with functional pathways. The same molecule may have high values in multiple columns of the amplitude matrix. Thus, MF techniques are able to account for the cumulative effect of genes that participate in multiple pathways. The properties of the amplitude matrix, and subsequently the interpretation of their values, depend critically on the specific MF problem and algorithm selected for analysis.
The three most prominent MF approaches are Principal Component Analysis (PCA), Independent Component Analysis (ICA), and Non-negative Matrix Factorization (NMF). Each of these techniques has a distinct mathematical formulation of a distinct MF problem that is described in the Box 2 and other reviews [5, 8, [19] [20] [21] [22] .
Briefly, PCA finds dominant sources of variation in high-dimensional datasets, inferring genes that distinguish samples. Maximizing the variability captured in certain factors, as 6 opposed to spreading relatively evenly among factors, may mix the signal from multiple CBPs in a single component. Therefore, PCA may conflate processes that sometimes occur and make interpretation of the amplitude matrix for define data-driven gene sets difficult.
To learn distinct processes, ICA learns factors that are statistically independent, resulting in more accurate associate with literature-derived gene sets [23] [24] [25] .
Comparison analyses in Rotival et al [26] found that ICA could identify modules with known biological function. NMF methods constrain all elements of the amplitude and pattern matrices to be greater than or equal to zero [27, 28] . NMF is well suited to transcriptional data, which is typically non-negative itself, and semi-NMF is also applicable to data that can have negative values. The assumptions of NMF model both the additive nature of CBPs and parsimony, generating solutions that are biologically intuitive to interpret [29] .
The solutions from both ICA and NMF may vary depending upon the initialization of the algorithm, leading to disparate amplitude matrices. Therefore, it is critical to ensure that particular solution used for analysis provides an optimal and robust solution before using the amplitude matrix to define data-driven gene signatures. Bayesian techniques to solve NMF were found to have more robust amplitude matrices than gradient-based techniques, and thus more accurate associations of the values in the amplitude matrix with functional pathways [5, 30] . These associations also depend critically on the input data. Therefore, to learn context dependent genes sets, MF can be applied to datasets with well-defined experimental perturbations [31] .
Standard gene set analysis can be applied directly to the values in each column of the amplitude matrix to associate the inferred factors with literature-curated sets.
New, context dependent gene sets can also be learned from the values in the amplitude matrix. Gene set annotations are often binary. Thresholding techniques to select which genes belong to a pathway from the amplitude matrix for binary membership provide an output similar to gene sets in databases [31, 32] . Other studies also integrate the literature-derived gene signatures in these thresholds to refine the context of pathway databases [30, 33] . The genes derived from these binarizations can be used as inputs to pathway analyses from differential expression statistics in independent datasets (Fig 3, right) and are analogous to the hierarchical-clustering based gene modules [34] and gene expression signatures from public domain studies in the MSigDB gene set database [35] . Another means of binarizing the data is to find genes that are most uniquely associated with a specific pattern to use as biomarkers of the cell type or process associated with that pattern [36, 37] . Selecting genes based upon these statistics can facilitate visualization of the CBPs in high-dimensional data [36] . Whereas binarization of genes with high weights can associate a single gene with multiple CBPs, the statistics for unique associations link a gene with only one CBP. Therefore, these statistics also define specific genes that may be biomarkers of the cell type/state or a process [36] (Fig 3, right) .
Although binary pathway models are substantially easier to interpret, continuous values from the original factorization provide a better model of the input data. Weighted gene signatures have been shown to be more robust to noise and missing values in the data [38] . If a gene's expression level is poorly measured in a sample, other genes in the same factor can imply the actual expression level of the gene in question. By considering each gene in the context of all other genes, factorization improves the robustness of findings. Further, continuous signatures can be associated directly with other samples using projection methods [38, 39] or profile correspondence methods [40] .
MF has also been applied to learn functional gene modules on non- 
MF learns relationships between samples that represent population stratification, tissue composition, cell types, disease subtypes, and clonality
Whereas each column of the amplitude matrix describes the relative contribution of molecules to a factor, each row of the pattern matrix describes the relative contribution of samples to a factor (Fig 2, Fig 4) . Sample groups can be learned by comparing the relative weights in each row of the pattern matrix ( Fig 4) . The pattern matrix from MF can also be binarized to perform clustering [47, 48] or kept as continuous values to define relationships between samples [49-51]. Just as molecules with high weights within a column of the amplitude matrix are associated with a common pathway, samples with high weights within a row of the pattern matrix can be assumed to share a common phenotype or CBP. Although here we refer to each of these samplelevel matrices as the Pattern matrix, numerous other terms have been adapted based on the MF method and its application (Box 3).
The application of PCA to SNP data from 3,000 European individuals [52] demonstrates inference of sample co-relationships using the pattern matrix and found that much of the variation in DNA sequence is explained by the longitude and latitude of an individual's country of origin. Additionally, statistical models can be formulated assuming that inheritance of an individual arises from proportions of ancestry in distinct populations through genetic admixture [52] . A MF based technique called sparse factor analysis also distinguishes these populations using GWAS data [53] . These analyses demonstrate that the ancestry of each individual is a dominant source variation in DNA sequence. Additional sources of variation in GWAS data arise from variants that give rise to disease risk, which can be shared among individuals with diverse genetic backgrounds [54]. These different sources of signal can give different sample groupings that reflect the biology of population genetics. For example, biologically a grouping inferred from GWAS which distinguishes ancestry is equally valid to a grouping inferred from the same GWAS data which distinguishes disease risk.
A single factorization of complex datasets can find multiple distinct sources of variation. For example, the power of MF to identify multiple sources of variation was seen when multiple technical factors from sample processing and biological factors were discovered in an ICA of gene expression profiles of 198 bladder cancer samples [55] . One factor in the pattern matrix of this analysis defined a CBP associated with gender. Because ICA simultaneously accounts for multiple factors in the data as separate rows in the same matrix, each row can fully distinguish a single biological grouping from the data.
Applying multiple types of MF techniques to the same dataset or a single MF to distinct subsets of a dataset can also find distinct sources of variability. For example, an NMF-class algorithm separated tissue-specific patterns from gene expression data for postmortem samples in the Genotype-Tissue Expression (GTEx) project [56]. This algorithm found a pattern that combined all samples from brain regions when applied to all tissue samples in GTEx, but separated the distinct brain regions when applied to only tissue samples from the brain. A different sparse NMF algorithm called CoGAPS simultaneously separated these brain regions from GTEx with additional patterns that are associated with the individual who donated those samples [36, 57] . Both of these algorithms are equally valid, and their distinct formulation gives rise to the distinct features observed in the data. Applications of multiple types of MF techniques, or even the same MF algorithm with different parameters, may infer several CBPs or phenotypes within a single dataset, in essence providing answers to different questions.
Analysis of a single dataset with one MF algorithm using different numbers of factors can reflect a hierarchy of biological processes. For example, applying CoGAPS to data from a set of head and neck tumors and controls for a range of dimensionalities was able to separate tumor and normal samples when limited to two patterns, but further decomposed the tumor samples into the two dominant clinical subtypes of head and neck cancer when identifying five patterns for the same data [58] . The hierarchical relationship between patterns has been used to assess the robustness of patterns to quantify the optimality of the factorization [59] and learn the optimal dimensionality of the factorization [60] . Other algorithms use statistical metrics to estimate the number of factors [12, 61] . While these algorithms quantify fit to the data, they may disregard the hierarchical nature of distinct CBPs learned by factoring biological data into multiple dimensions. This observation highlights the complexity of estimating the number of factors for optimal MF analysis of biological data (see Outstanding Questions).
Intra-and inter-tumor heterogeneity introduce a further degree of complexity to MF analysis of biological variation in their molecular data. Computational microdissection algorithms estimate the proportion of distinct cell types within a bulk samples by applying MF to genes whose expression are uniquely associated with each cell type [62] . Subsetting the data to different genes may give rise to different factors that represent different CBPs. Nonetheless, CoGAPS analysis of data subsets that were obtained by selecting equally sized sets of random genes found that the pattern matrices were consistent for each random gene set in expression data [36, 63] . These results suggest that the dependency of a MF on the specific genes used for analysis may depend on the heterogeneity of the signal in the data matrix.
Even a pure tumor tissue can contain numerous subclones due to the accumulation of different driver events during tumor evolution. New MF techniques have been developed to estimate the proportion of the tumor that arises from each subclone [61, [64] [65] [66] [67] . Assumptions about the evolutionary mechanisms of the accumulation of molecular alterations can also be encoded in the factorization to model the resulting heterogeneity of these clones [12, 61] . These studies demonstrate that encoding prior knowledge into MF can focus the resulting factors to reflect one of the equally valid biological groupings within the data. Both ICA and NMF were found to have signatures characterizing the yeast cell cycle and metabolism in early time-course microarray experiments [70, 71] . The Sparse NMF techniques using Bayesian method had patterns that reflected the smooth dynamics of these phases [30, 70] . This approach has been shown to simultaneously learn pathway inhibition and transitory response to chemical perturbation of cancer cells [72] and relate the the changes in phospho-proteomics trajectories between multiple therapies [73] . Similar analysis of healthy brain tissues learned the dynamics of transcriptional alterations common to the ageing process from multiple individuals [63] .
From snapshots to moving pictures: simplifying time course analysis
MF techniques designed for cancer subclones described in the previous section have also been applied to repeat samples to learn the dynamics of cancer development, elucidating the molecular mechanisms that give rise to therapeutic resistance and metastasis. Even if the same number of biological features exist, the rate or timing of related features in different molecular modalities may be offset [74] . These discrepancies by data modality suggest that different regulatory mechanisms may be responsible for initiating and stabilizing the malignant phenotype [74] .
Integrated analysis of multiple omics data
Multi-omics data are generated in order to elucidate the molecular networks that govern phenotypes. MF can be applied to learn shared features between datasets [7, 8, 75] . Integration may occur between datasets with distinct samples measured with the same molecular type using different measurement technologies or in distinct technical batches. For example, an analysis of multiple microarray studies of the same cell lines across different platforms with an MF approach designed to find components that maximize covariance or correlated information discovers which microarray platforms have the most informative set of genes [76] . Gene regulation can also be inferred by applying MF to data with different molecular components of the same [112] , multi-task learning [113] semi-supervised learning [114] , compressed sensing [115] , and similarity-based learning [116, 117] . Dimension reduction of biological data with MF highlights perspectives and questions that investigators have not yet considered, and also enables tractable exploration of otherwise massive datasets.
Different classes of techniques solve MF, including gradient-based and
probabilistic methods (see Box 1) . Distinct MF problems each aim to identify certain types of features, in some cases different algorithms will learn distinct features from the same dataset. Therefore, investigators may benefit from applying multiple techniques with different properties, or by carefully considering the dataset and question to select exactly the right technique for that question. The features MF techniques extract are constrained by the dataset used to train them. These algorithms cannot learn unmeasured features nor can they correct for complete overlap between technical artifacts and biological conditions. Thus, being mindful of experimental design when selecting datasets and choosing those that are broad enough to cover the relevant sources of variability are essential. Advances to MF and related techniques will be essential to powering systems level analyses from big data (see Outstanding Questions). 19 Tumor Heterogeneity using RNA-Seq Counts. at <https://arxiv.org/abs/1702.07981> 
Glossary (450 words)
Amplitude matrix The matrix learned from MF that contains molecules in rows and factors in columns. Each column represents the relative contribution of the genes in a factor, which can be used to define a molecular signature for a CBP.
Complex biological process (CBP)
The coregulation or coordinated effect of multiple molecular species resulting in one or more phenotypes examples can range from activation of multiple proteins in a single cellular signaling pathway to epistatic regulation of development.
Computational microdissection A computational method to learn the composition of a heterogeneous sample, e.g., the cell types in a tissue sample.
Independent Component Analysis (ICA)
A MF technique that learns statistically independent factors.
Matrix Factorization (MF)
A technique to approximate a data matrix by the product of two matrices (see Box 1), one of which we call the amplitude matrix and the other the pattern matrix.
Non-negative Matrix Factorization (NMF) A MF technique for which all elements
of the amplitude and pattern matrices are greater than or equal to zero.
Pattern matrix
The matrix learned from MF that contains factors in rows and samples in columns. Each row represents the relative contribution of the samples in a factor, which can be used to define the relative activity of CBPs in each sample. Data-driven gene sets can also be defined from this matrix directly using binarization, and used in place of literature curated gene sets to query CBPs in a new dataset. Sets defined from molecules with high-weights in the amplitude matrix comprise signatures akin to many curated gene set resources whereas molecules that are most uniquely associated with a specific factor (purple box) may be biomarkers. 
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